These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10861836)

  • 1. ERK1/2 phosphorylation, induced by electromagnetic fields, diminishes during neoplastic transformation.
    Jin M; Blank M; Goodman R
    J Cell Biochem; 2000 Jun; 78(3):371-9. PubMed ID: 10861836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5'-Nitro-indirubinoxime inhibits epidermal growth factor- and phorbol ester-induced AP-1 activity and cell transformation through inhibition of phosphorylation of Pin1.
    Khanal P; Choi HK; Namgoong GM; Ahn SG; Yoon JH; Sohn H; Choi HS
    Mol Carcinog; 2011 Dec; 50(12):961-71. PubMed ID: 21400615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
    Wen-Sheng W
    Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
    Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
    Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha.
    Wadsworth TL; McDonald TL; Koop DR
    Biochem Pharmacol; 2001 Oct; 62(7):963-74. PubMed ID: 11543732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS; Kim SH; Song YS; Surh YJ
    Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of p38 MAP kinase increases okadaic acid mediated AP-1 expression and DNA binding but has no effect on TRE dependent transcription.
    Rosenberger SF; Gupta A; Bowden GT
    Oncogene; 1999 Jun; 18(24):3626-32. PubMed ID: 10380884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A; Agarwal R; Agarwal C
    Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of c-Fos/JunD in protecting stress-induced cell death.
    Zhou H; Gao J; Lu ZY; Lu L; Dai W; Xu M
    Cell Prolif; 2007 Jun; 40(3):431-44. PubMed ID: 17531086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
    Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
    Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH activates ERK1/2 leading to the induction of c-fos and LHbeta protein expression in LbetaT2 cells.
    Liu F; Austin DA; Mellon PL; Olefsky JM; Webster NJ
    Mol Endocrinol; 2002 Mar; 16(3):419-34. PubMed ID: 11875099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of JNK and p38 MAPK activities in UVA-induced signaling pathways leading to AP-1 activation and c-Fos expression.
    Silvers AL; Bachelor MA; Bowden GT
    Neoplasia; 2003; 5(4):319-29. PubMed ID: 14511403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of apoptotic resistance in arsenic-induced malignant transformation: role of the JNK signal transduction pathway.
    Qu W; Bortner CD; Sakurai T; Hobson MJ; Waalkes MP
    Carcinogenesis; 2002 Jan; 23(1):151-9. PubMed ID: 11756236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion.
    Hartkamp J; Troppmair J; Rapp UR
    Cancer Res; 1999 May; 59(9):2195-202. PubMed ID: 10232608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression.
    Ramos-Nino ME; Timblin CR; Mossman BT
    Cancer Res; 2002 Nov; 62(21):6065-9. PubMed ID: 12414630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
    Ferrer I; Friguls B; Dalfó E; Planas AM
    Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
    Okumura K; Shirasawa S; Nishioka M; Sasazuki T
    Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhein inhibits TPA-induced activator protein-1 activation and cell transformation by blocking the JNK-dependent pathway.
    Lin S; Li JJ; Fujii M; Hou DX
    Int J Oncol; 2003 Apr; 22(4):829-33. PubMed ID: 12632075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes.
    Johansen C; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L
    J Invest Dermatol; 2003 Apr; 120(4):561-70. PubMed ID: 12648218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of activator protein 1 by barbiturates is mediated by differential effects on mitogen-activated protein kinases and the small G proteins ras and rac-1.
    Humar M; Andriopoulos N; Pischke SE; Loop T; Schmidt R; Hoetzel A; Roesslein M; Pahl HL; Geiger KK; Pannen BH
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1232-40. PubMed ID: 15263067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.